Moreover, Omar Saeed et al. reported that the pharmacologic suppression of hepcidin increases the expression of ABCA1 and ABCG1 and lipid efflux via the macrophage-specific expression of cholesterol efflux transporters and reduces foam cell formation and atherosclerosis [12]. Here, ABCA1 is linked to atherosclerosis.